M&A activity in Genericshttps://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11613023/Drug-maker-Endo-strikes-again-with-8bn-bid-for-US-rival.html
A good read. A few things jump out, 1) portfolio of 100 drugs, 2) M&A actvity in this space 3) high valuation for a relatively small player (albeit in a much larger market).
Really not that hard to imagine Vanc sporting a $500m CAD market cap in a couple of years as long as they execute!!
Good luck all!
SDM